Melki R, Colomb E, Lefort N, Brézin A P, Garchon H-J
INSERM U580, Hôpital Necker, Paris, France.
J Med Genet. 2004 Sep;41(9):647-51. doi: 10.1136/jmg.2004.020024.
Primary open-angle glaucoma (POAG) is a leading cause of visual impairment worldwide and a complex genetic disorder that affects mostly adults. Mutations in the MYOCILIN (MYOC) and OPTINEURIN genes account for rare forms with a Mendelian inheritance and for <5% of all POAG cases. The CYP1B1 gene, a member of the cytochrome P450 gene family, is a major cause of primary congenital glaucoma (PCG), a rare and severely blinding disease with recessive inheritance. However, CYP1B1 mutations have also been associated with cases of juvenile-onset glaucoma in some PCG families or shown to modify the age of onset of glaucoma linked to a MYOC mutation in a large family.
To investigate the role of CYP1B1 mutations in POAG predisposition, irrespective of the presence of a MYOC mutation.
CYP1B1 coding region variation was characterised by denaturing high performance liquid chromatography (DHPLC) and sequencing in 236 unrelated French Caucasian POAG patients and 47 population-matched controls.
Eleven (4.6%) patients carried one or two mutated CYP1B1 gene(s) and no MYOC mutation. They showed juvenile or middle-age onset of disease (median age at diagnosis, 40 years, range 13-52), significantly earlier than in non-carrier patients. Apart from one, all mutations detected in POAG patients were previously associated with PCG.
CYP1B1 mutations might pose a significant risk for early-onset POAG and might also modify glaucoma phenotype in patients who do not carry a MYOC mutation.
原发性开角型青光眼(POAG)是全球视力损害的主要原因,是一种主要影响成年人的复杂遗传疾病。肌纤蛋白(MYOC)和视紫质神经元(OPTINEURIN)基因的突变导致罕见的孟德尔遗传形式,占所有POAG病例的不到5%。细胞色素P450基因家族成员CYP1B1基因是原发性先天性青光眼(PCG)的主要病因,PCG是一种罕见且严重致盲的隐性遗传疾病,但CYP1B1突变也与一些PCG家族中的青少年型青光眼病例有关,或在一个大家庭中显示可改变与MYOC突变相关的青光眼发病年龄。
研究CYP1B1突变在POAG易感性中的作用,而不考虑是否存在MYOC突变。
通过变性高效液相色谱(DHPLC)和测序对236名无亲缘关系的法国白种人POAG患者和47名匹配人群对照的CYP1B1编码区变异进行特征分析。
11名(4.6%)患者携带一个或两个CYP1B1基因突变且无MYOC突变。他们表现为青少年或中年发病(诊断时的中位年龄为40岁,范围为13 - 52岁),明显早于非携带者患者。除一例之外,在POAG患者中检测到的所有突变之前都与PCG相关。
CYP1B1突变可能对早发性POAG构成重大风险,并且可能改变未携带MYOC突变患者的青光眼表型。